> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA in Pistoia Alliance Working Group
- URL: https://www.fdaweb.com/fda-in-pistoia-alliance-working-group/
- Published: 2022-09-13T12:00:00.000Z
- Updated: 2026-09-14T17:59:02.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5152725

Liaisons from CDER will be part of a new In Vitro Pharmacology Working Group being assembled by Pistoia Alliance, a global not-for-profit that says it advocates for greater collaboration in life sciences research and development. The alliance [says](https://www.pistoiaalliance.org/news/pistoia-alliance-fda-collaborate-to-establish-in-vitro-pharmacology-working-group/?ref=fdaweb.com) the working group also will have representatives from biopharmaceutical companies, contract research organizations, technology suppliers, and other regulatory agencies.

“The mission of the group is to improve the data structure and standards for *in vitro* pharmacology (IVP) data in regulatory submissions, to enable faster reviews and interpretations of submissions, and ensure new therapies reach patients as quickly as possible,” the alliance says.

The working group will create a shared data structure to ensure data consistency in IVP screening across all stakeholders. “The current lack of consistent standards around data input, reporting, and submission is a common challenge that causes significant inconsistencies in regulatory submissions and limits the accessibility and interoperability of the data,” Pistoia says.